Draupnir Bio announces equity investments totalling €12 million with MP Healthcare, EIFO, Gilde Healthcare Partners, Inkef Capital and Novo Holdings

Biotech Health services

Denmark

Netherlands

United States

Investments

05 July 2024

Share:

Draupnir Bio (company)

Denmark

Biotech Health services

Total investments received (USD): 46.13m

Round value (USD): 12.92m

Round investors: Gilde Healthcare Inkef Capital Novo A/S EIFO MP Healthcare Venture Management

Company: Draupnir Bio

Industry: Biotech Health services

Related deals

Enduro Genetics raised €12m in Series A funding from Supernova Invest, NOON Ventures, and Sandwater.

Biotech Health services Manufacturing

Denmark

France

Norway

Investments 04 January 2025

HERVolution Therapeutics raised $11.7M in Series A funding led by the Serum Institute of India (SII), joined by European Innovation Council (EIC) Fund

Biotech Health services Pharma

Denmark

Belgium

India

Investments 06 December 2024

Freya Biosciences raised more capital funding in a $11.8 million series A extension.

Biotech Health services Manufacturing

Denmark

France

United States

Investments 30 September 2024

Kvantify in a €10 million seed round led by Dreamcraft Ventures, joined by Lundbeckfonden, BioCapital, 2degrees, Redstone VC, 2xN, and EIFO.

AI (big data) Biotech Electronics Hardware Health services Manufacturing Software Services

Denmark

Germany

United Kingdom

Investments 29 June 2024

Adcendo raises DKK 90M in a new series A extension led by Dawn Biopharma, w/ Novo, Ysios Capital, RA Capital, HealthCap, Glide and Pontifax Venture Capital.

Biotech Health services

Denmark

Sweden

United States

Spain

Israel

Netherlands

United Kingdom

Investments 07 April 2024